20mg - 40mg
Olmesan® (Olmesartan Medoxomil), a prodrug, is hydrolyzed to Olmesartan during absorption from the gastrointestinal tract. Olmesartan is a selective AT1 subtype angiotensin II receptor antagonist. Olmesan®(olmesartan Medoxomil) is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.
landline : +218-21-350-4495
Mobile : +218–91–6792805
16 st branch of 20 Ramadan road, Soug aljomaa
Tripoli – Libya
© 2021 ramsa.ly, All Rights Reserved